NEW YORK (GenomeWeb News) – Geospiza today announced it has received a $1.2 million Small Business Innovation Research Grant to develop a new application that can identify and visualize DNA sequence variations in cancer tissue compared to normal tissue.
The Seattle-based bioinformatics software firm will collaborate with researchers from Weill Cornell Medical College in New York and the Mayo Clinic in Rochester, Minn., to develop the new application on GeoSpiza's GeneSifter cloud computing platform.
The two-year grant is from the National Human Genome Research Institute.
David Smith, a professor of laboratory medicine and pathology at the Mayo Clinic, said that new sequencing technologies have opened new avenues of cancer biology research.
"It's clear that the next generation of diagnostic tests can only be made by effectively combining whole transcriptome analysis with genome sequences on a per patient per sample basis," he said in a statement. "The application developed through this work will be well suited for translating research observations to actionable clinical tests."